WallStreetZenWallStreetZen

NASDAQ: NKTR
Nektar Therapeutics Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Nektar Therapeutics earnings were -$120.7M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest NKTR earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$35.5M, down 14.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NKTR reported annual earnings of -$119.0M, with -56.9% growth.

NKTR earnings history

Current Revenue
$62.6M
Current Earnings
-$120.7M
Current Profit Margin
-192.9%

NKTR Return on Equity

Current Company
-356.8%
Current Industry
-21.2%
Current Market
35.1%
NKTR's Return on Equity (-356.8%)... subscribe to Premium to read more.
High Return on Equity Performance

NKTR undefined

Current Company
-45.2%
Current Industry
-8.8%
NKTR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NKTR announces earnings.

NKTR undefined

Current Company
-40.25%
Current Industry
-3.4%
NKTR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NKTR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NKTR-$93.43M-$120.74MN/A-$7.82
AVBP-$151.40M-$151.40MN/A-$4.24
ABUS-$41.48M-$42.28MN/A-$0.23
CMPX-$64.35M-$65.81MN/A-$0.45
BCAX-$120.77M-$121.52MN/A$5.37
View Top Biotech Stocks

Nektar Therapeutics Earnings Reports & History FAQ

What were Nektar Therapeutics's earnings last quarter?

Nektar Therapeutics (NASDAQ: NKTR) reported Q3 2025 earnings per share (EPS) of -$1.87, up 29.7% year over year. Total NKTR earnings for the quarter were -$35.52 million. In the same quarter last year, Nektar Therapeutics's earnings per share (EPS) was -$2.66.

If you're new to stock investing, here's how to buy Nektar Therapeutics stock.

Is Nektar Therapeutics profitable or losing money?

As of the last Nektar Therapeutics earnings report, Nektar Therapeutics is currently losing money. Nektar Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$120.74 million, a 28.26% decrease year over year.

What was NKTR's earnings growth in the past year?

As of Nektar Therapeutics's earnings date in Q4 2025, Nektar Therapeutics's earnings has grown year over year. NKTR earnings in the past year totalled -$120.74 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.